Baseline Circulating and Tumor γδ T Cells and Early Circulating CD8+PD-1+ Expansion Predict Response to Atezolizumab–Bevacizumab in HCC
Year: 2026
Type: article
Source: Clinical Cancer Research
Authors: Isabelle Galy-Fauroux, Amna Asif-Laidin, Manon Evain, Joana Goncalves Araujo, Claudia Campani, Chiara Cremolini, Edouard Larrey, Sara Lonardi, Sayma Chaibi, Julien Taieb, Ludovic Furia, David Tougeron, Sarah Mouri, Janick Selves, Camille Reiss, Pierre Laurent-Puig, Jessica Zucman-Rossi, Chantal Desdouets, Jean-Charles Nault, Jean-Pierre Couty, Manon Allaire
Institutions: Inserm, Université Paris Cité, Sorbonne Université, Centre de Recherche des Cordeliers, La Ligue Contre le Cancer, Assistance Publique – Hôpitaux de Paris, Azienda Ospedaliera Universitaria Pisana, Pitié-Salpêtrière Hospital, Istituto Oncologico Veneto, Hôpital Européen Georges-Pompidou, Centre Hospitalier Universitaire de Poitiers, Institut universitaire du cancer de Toulouse Oncopole
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7203628768
FWCI:
Cites:
Cited by:
Related to: